Upload Avatar (500 x 500)
Zhang Zheng
zhangzheng1975@aliyun.com
Chinese, English
Guangdong
Southern University of Science and Technology
Medical School
  • 2002-2005: PhD in Pathology and Pathophysiology, Academy of Military Medical Sciences
  • 1999-2002: Master of Medical Science in Physiology, Fourth Military Medical University
  • 1994-1999: Bachelor of Medical Science in Clinical Medicine, Fourth Military Medical University
  • Recipient of the National Science Fund for Distinguished Young Scholars
  • Recipient of the National Innovation Competition Award
  • 2018.07-: Vice President and Director of Research Institute, Second Affiliated Hospital of Southern University of Science and Technology
  • 2015.07-2018.06: Researcher, Clinical Research Management Center, PLA 302 Hospital
  • 2013.09-2015.06: Researcher, Biotherapy Research Center, PLA 302 Hospital
  • 2013.09-2014.09: Postdoctoral Fellow, Department of Immunology, University of North Carolina (UNC)
  • 2010.09-2013.08: Associate Researcher, Biotherapy Research Center, PLA 302 Hospital
  • 2009.09-2010.03: Visiting Scholar, Department of Immunology, University of North Carolina (UNC)
  • 2007.09-2010.08: Associate Researcher, Institute of Infectious Diseases, PLA 302 Hospital
  • 2005.07-2007.09: Assistant Researcher, Institute of Infectious Diseases, PLA 302 Hospital
  • National Science Fund for Distinguished Young Scholars (2020)
  • National Innovation Competition Award (2020)
  • Key R&D Program of the Ministry of Science and Technology (2020)
  • Shenzhen Municipal National Leading Talent (2018)
  • National Talents Project for Outstanding Contribution (2017)
  • National Excellent Youth Fund (2013)
Pathogen infection immunopathogenesis
Immunotherapy strategies
  • Potent human neutralizing antibodies elicited by SARS-CoV-2 infection, Zhang Z et al., 2020
  • Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2, Zhang Z et al., 2021
  • Host-viral infection maps reveal signatures of severe COVID-19 patients, Zhang Z et al., 2020
  • SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation, Zhang Z et al., 2021
  • Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19, Zhang Z et al., 2020
  • Sustained IFN-I Stimulation Impairs MAIT Cell Responses to Bacteria by Inducing IL-10 during chronic HIV-1 Infection, Zhang Z et al., 2020
  • Plasmacytoid dendritic cells promote HIV-1-induced group-3 innate lymphoid cell depletion, Zhang Z et al., 2015
  • Hyper–Cytolytic Activity of Hepatic Natural Killer Cells Correlates with Liver Injury in Chronic Hepatitis B Patients, Zhang Z et al., 2011
  • Dynamic programmed death-1 expression on virus-specific CD8 T cells correlates with the outcome of acute hepatitis B, Zhang Z et al., 2008
Immunopathogenesis Pathogens Infection Immunotherapy Therapy Strategies Disease Mechanisms Research Clinical

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.